Loading clinical trials...
Loading clinical trials...
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study: A Phase II Study of Chemo - Hormonal Therapy and Radiation in High Risk Prostate Cancer
Conditions
Interventions
Docetaxel
Leuprolide Acetate (Eligard®)
+2 more
Locations
1
Canada
Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
Start Date
May 1, 2007
Primary Completion Date
February 1, 2017
Completion Date
February 1, 2017
Last Updated
March 19, 2014
NCT07225946
NCT04868604
NCT00756665
NCT05743621
NCT04104776
NCT06242119
Lead Sponsor
Nova Scotia Cancer Centre
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions